Close Menu

NEW YORK – NanoView Biosciences said on Wednesday that it has signed an exclusive agreement with Quantum Design to distribute its ExoView platform in China.

The research-use-only ExoView platform is an antibody labeling and imaging-based tool that offers high-resolution sizing, counting, and phenotyping of extracellular vesicles and viral vectors. Boston-based NanoView noted that the platform requires low sample input, no extensive sample preparation or purification, and minimal hands-on time.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.